Disproportionality Analysis of Reporting Signals for Pericardial Disorders in the FDA Adverse Event Reporting System, 2000 to 2025. (PubMed, Curr Drug Saf) - Oct 15, 2026 - "Immunomodulating, antineoplastic, and antithrombotic agents generated reporting signals involving pericardial disorders, with sex-based differences and reported drug classes and outcomes. These findings do not establish causality and warrant confirmatory studies."
Adverse events • Journal • Cardiovascular • Oncology • Pediatrics
|
|
Courtney E George; Dante T Mento; Hailey N Goudy; Kenneth L McCall; Kristin T Bush; Nicholas C Schwier
|